Faculty profile

Sambasivarao Damaraju

ResearcherLaboratory Medicine and PathologyUniversity of Alberta

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Alberta directory, so their courses may be missing. Find their university profile.

Sambasivarao Damaraju

Researcher

Laboratory Medicine and Pathology

Health Sciences

University of Alberta

Edmonton, Alberta, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
3 publications in the last five years, latest in 2025.
Senior (last) author on 1 recent paper, a sign of leading a research group.
Principal investigator on 1 research grant (1 CIHR), most recently in 2013.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Cancer Cachexia Genotype Palliative Care

Latest papers

Pathways Contributing to Chemotherapy-Induced Myotoxicity Are Attenuated by EPA + DHA in a Clinically Relevant Model of Colorectal Cancer.
Journal of cachexia, sarcopenia and muscle · 2025
Molecular subtypes of human skeletal muscle in cancer cachexia.
Nature · 2025 · senior author
Personalized breast cancer onset prediction from lifestyle and health history information.
PloS one · 2022

All 46 publications

Latest funding

Dietary EPA and DHA Enhance Tumor Response and Protect against Muscle Loss and Myosteatosis During Chemotherapy Treatment
CIHR · 2019 · Co-investigator
$745,875
Cancer Cachexia: Phenotype Definition, Markers for Genetic Predisposition and Prognosis
CIHR · 2013 · Nominated PI
$470,364

All 2 grants and awards

46 publications.

Pathways Contributing to Chemotherapy-Induced Myotoxicity Are Attenuated by EPA + DHA in a Clinically Relevant Model of Colorectal Cancer.

Isesele PO, Bhatt BJ, Baracos VE, Damaraju S, Mazurak VC

Journal of cachexia, sarcopenia and muscle2025

DOI: 10.1002/jcsm.70110 PMID: 41243421

Molecular subtypes of human skeletal muscle in cancer cachexia.

Bhatt BJ, Ghosh S, Mazurak V, Brun AQ, Bathe O, Baracos VE, Damaraju S

Nature2025Senior author

DOI: 10.1038/s41586-025-09502-0 PMID: 40931079

Personalized breast cancer onset prediction from lifestyle and health history information.

Qi SA, Kumar N, Xu JY, Patel J, Damaraju S, Shen-Tu G, Greiner R

PloS one2022

DOI: 10.1371/journal.pone.0279174 PMID: 36534670

Uridine Glucuronosyltransferase 2B7 Polymorphism-Based Pharmacogenetic Dosing of Epirubicin in FEC Chemotherapy for Early-Stage Breast Cancer.

Joy AA, Vos LJ, Pituskin E, Cook SF, Bies RR, Vlahadamis A, King K, Basi SK, Meza-Junco J, Mackey JR, Stanislaus A, Damaraju VL, Damaraju S, Sawyer MB

Clinical breast cancer2021

DOI: 10.1016/j.clbc.2021.03.001 PMID: 33832852

Corrigendum to 'Identification of proteins and cellular pathways targeted by 2-nitroimidazole hypoxic cytotoxins' [Redox Biol. 41 (2021) 101905].

Rashed FB, Stoica AC, MacDonald D, El-Saidi H, Ricardo C, Bhatt B, Moore J, Diaz-Dussan D, Ramamonjisoa N, Mowery Y, Damaraju S, Fahlman R, Kumar P, Weinfeld M

Redox biology2021

DOI: 10.1016/j.redox.2021.101986 PMID: 33910780

Identification of proteins and cellular pathways targeted by 2-nitroimidazole hypoxic cytotoxins.

Rashed FB, Stoica AC, MacDonald D, El-Saidi H, Ricardo C, Bhatt B, Moore J, Diaz-Dussan D, Ramamonjisoa N, Mowery Y, Damaraju S, Fahlman R, Kumar P, Weinfeld M

Redox biology2021

DOI: 10.1016/j.redox.2021.101905 PMID: 33640700

BIK drives an aggressive breast cancer phenotype through sublethal apoptosis and predicts poor prognosis of ER-positive breast cancer.

Pandya V, Githaka JM, Patel N, Veldhoen R, Hugh J, Damaraju S, McMullen T, Mackey J, Goping IS

Cell death & disease2020

DOI: 10.1038/s41419-020-2654-2 PMID: 32528057

Fine-mapping of a novel premenopausal breast cancer susceptibility locus at Chr4q31.22 in Caucasian women and validation in African and Chinese women.

Kumaran M, Ghosh S, Joy AA, Mackey JR, Cass CE, Zheng W, Yasui Y, Damaraju S

International journal of cancer2020Senior author

DOI: 10.1002/ijc.32407 PMID: 31087647

Clinical and biological characterization of skeletal muscle tissue biopsies of surgical cancer patients.

Anoveros-Barrera A, Bhullar AS, Stretch C, Esfandiari N, Dunichand-Hoedl AR, Martins KJB, Bigam D, Khadaroo RG, McMullen T, Bathe OF, Damaraju S, Skipworth RJ, Putman CT, Baracos VE, Mazurak VC

Journal of cachexia, sarcopenia and muscle2019

DOI: 10.1002/jcsm.12466 PMID: 31307124

Oncogenic activity of poly (ADP-ribose) glycohydrolase.

Marques M, Jangal M, Wang LC, Kazanets A, da Silva SD, Zhao T, Lovato A, Yu H, Jie S, Del Rincon S, Mackey J, Damaraju S, Alaoui-Jamali M, Witcher M

Oncogene2019

DOI: 10.1038/s41388-018-0568-6 PMID: 30459355

Something wrong or missing on this profile? Suggest a correction

Sambasivarao Damaraju

Research

Latest papers

Latest funding

Pathways Contributing to Chemotherapy-Induced Myotoxicity Are Attenuated by EPA + DHA in a Clinically Relevant Model of Colorectal Cancer.

Molecular subtypes of human skeletal muscle in cancer cachexia.

Personalized breast cancer onset prediction from lifestyle and health history information.

Uridine Glucuronosyltransferase 2B7 Polymorphism-Based Pharmacogenetic Dosing of Epirubicin in FEC Chemotherapy for Early-Stage Breast Cancer.

Corrigendum to 'Identification of proteins and cellular pathways targeted by 2-nitroimidazole hypoxic cytotoxins' [Redox Biol. 41 (2021) 101905].

Identification of proteins and cellular pathways targeted by 2-nitroimidazole hypoxic cytotoxins.

BIK drives an aggressive breast cancer phenotype through sublethal apoptosis and predicts poor prognosis of ER-positive breast cancer.

Fine-mapping of a novel premenopausal breast cancer susceptibility locus at Chr4q31.22 in Caucasian women and validation in African and Chinese women.

Clinical and biological characterization of skeletal muscle tissue biopsies of surgical cancer patients.

Oncogenic activity of poly (ADP-ribose) glycohydrolase.

Dietary EPA and DHA Enhance Tumor Response and Protect against Muscle Loss and Myosteatosis During Chemotherapy Treatment

Cancer Cachexia: Phenotype Definition, Markers for Genetic Predisposition and Prognosis

Frequent collaborators

Yutaka Yasui

Liang Li

Olga Kovalchuk

Richard Fahlman

Edith Pituskin

Michael Weinfeld

Vickie Baracos

Michael Witcher

Wan Lam

Todd McMullen

Moulay Alaoui-Jamali

Mark Clemons

Sonia Del Rincon

Vera Mazurak

Dindial Ramotar

Oliver Bathe

Sonia Del Rincon

Marina Mourtzakis

Sambasivarao Damaraju

Research

Latest papers

Latest funding

Pathways Contributing to Chemotherapy-Induced Myotoxicity Are Attenuated by EPA&#x2009;+&#x2009;DHA in a Clinically Relevant Model of Colorectal Cancer.

Molecular subtypes of human skeletal muscle in cancer cachexia.

Personalized breast cancer onset prediction from lifestyle and health history information.

Uridine Glucuronosyltransferase 2B7 Polymorphism-Based Pharmacogenetic Dosing of Epirubicin in FEC Chemotherapy for Early-Stage Breast Cancer.

Corrigendum to 'Identification of proteins and cellular pathways targeted by 2-nitroimidazole hypoxic cytotoxins' [Redox Biol. 41 (2021) 101905].

Identification of proteins and cellular pathways targeted by 2-nitroimidazole hypoxic cytotoxins.

BIK drives an aggressive breast cancer phenotype through sublethal apoptosis and predicts poor prognosis of ER-positive breast cancer.

Fine-mapping of a novel premenopausal breast cancer susceptibility locus at Chr4q31.22 in Caucasian women and validation in African and Chinese women.

Clinical and biological characterization of skeletal muscle tissue biopsies of surgical cancer patients.

Oncogenic activity of poly (ADP-ribose) glycohydrolase.

Dietary EPA and DHA Enhance Tumor Response and Protect against Muscle Loss and Myosteatosis During Chemotherapy Treatment

Cancer Cachexia: Phenotype Definition, Markers for Genetic Predisposition and Prognosis

Frequent collaborators

Yutaka Yasui

Liang Li

Olga Kovalchuk

Richard Fahlman

Edith Pituskin

Michael Weinfeld

Vickie Baracos

Michael Witcher

Wan Lam

Todd McMullen

Moulay Alaoui-Jamali

Mark Clemons

Sonia Del Rincon

Vera Mazurak

Dindial Ramotar

Oliver Bathe

Sonia Del Rincon

Marina Mourtzakis

Pathways Contributing to Chemotherapy-Induced Myotoxicity Are Attenuated by EPA + DHA in a Clinically Relevant Model of Colorectal Cancer.